- Researchers at Hong Kong University of Science and Technology say the drug, PLB-1001, can stall the effects of rare disease Secondary Glioblastoma
- The drug showed signs of success in a three-month trial on patients whose cancer was resistant to chemotherapy
Patients diagnosed with a deadly brain cancer may soon see new hope of living longer following a breakthrough by researchers from a university in Hong Kong, the school announced on Monday.
Around 200 Hongkongers are afflicted by brain cancers every year; among them, about 20 are diagnosed with a rare but aggressive type called Secondary Glioblastoma, known as sGMB.
Current treatments for sGMB, including chemotherapy and orally administered drugs, have proven to be ineffective, with a mortality rate of almost 100 per cent.
Now, in a world first, scientists from the Hong Kong University of Science and Technology (HKUST) have announced a discovery that a type of gene mutation is the major culprit behind the cancer’s aggressive progression.